NCT05219435
Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT05219435
Title Study of NIVOLUMAB/IPILIMUMAB Maintenance in Unresectable Locally Advanced or Metastatic Urothelial Cancer (VEXILLUM)
Acronym VEXILLUM
Recruitment Active, not recruiting
Gender both
Phase Phase II
Variant Requirements No
Sponsors Spanish Oncology Genito-Urinary Group
Indications
Therapies
Age Groups: adult | senior
Covered Countries ESP

Facility Status City State Zip Country Details
Hospital Universitario Juan Ramón Jiménez Huelva Andalusia 21005 Spain Details
Hospital Universitario Virgen de la Macarena Seville Andalusia 41009 Spain Details
Hospital Clínico Universitario de Zaragoza Zaragoza Aragon 50009 Spain Details
Hospital Universitario Son Espases Palma de Mallorca Balearic Islands 07120 Spain Details
Complejo asistencial universitario de Salamanca Salamanca Castille and León 37007 Spain Details
Hospital Universitario de Toledo Toledo Castille-La Mancha 45004 Spain Details
Hospital Clínic de Barcelona Barcelona Catalonia 08036 Spain Details
Hospital Clínico Universitario de Santiago de Compostela Santiago de Compostela Galicia 15706 Spain Details
Hospital Universitario Ramón y Cajal Madrid Madrid 28034 Spain Details
Hospital Universitario 12 de Octubre Madrid Madrid 28041 Spain Details
Hospital Universitario Central de Asturias Oviedo Principality of Asturias 33011 Spain Details
Hospital Universitario de la Ribera Alzira Valencia 46600 Spain Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field